Continuing Education

Insights on Prescribing and Dispensing Controlled Substances Mini Conferences

FREE 3 HOUR CONTINUING EDUCATION OPPORTUNITY

Numerous state and federal laws/regulations relate to controlled substances, which can be confusing to prescribers and dispensers. This program aims to clarify those rules and regulations, as well as best practices.

Target Audience:

This knowledge-based course is intended for Pharmacists (ACPE), Pharmacy Technicians (ACPE), Physicians (ACCME), Physician Assistants (ACCME), Nurse Practitioners (ACCME), and Dentists (AL board approval).

Learning Objectives:

1. Review rules and regulations related to controlled substances.
2. Discuss differences in state and federal rules and regulations related to controlled substances.
3. Examine best practices for prescribing and dispensing controlled substances.

Tuesday, June 24, 2025, 6:00 PM - 9:00 PM, USA Faculty Club, 6350 Fincher Road, Mobile, AL 36688

Tuesday, July 29, 2025, 6:00 PM - 9:00 PM, Auburn Research Park-540 at the Park, Devall Room, 570 Devall Drive, Auburn, AL 36832

Tuesday, August 19, 2025, 6:00 PM - 9:00 PM, UAB Huntsville Regional Medical Campus, Classroom-Training Room, 301 Governors Drive SW, Huntsville, AL 35801

Auburn University Harrison College of Pharmacy COACH Courses

This project is supported by the Alabama Department of Public Health through a grant from the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Department of Justice's Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Precention, the Office for Victims of Crime, and the SMART Office. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the U.S. Department of Justice.

Continuing Education Home Study

We are happy to share a free home study on Alabama's Prescription Drug Monitoring Program. This presentation is a review of the history and laws pertaining to the Alabama PDMP; it provides information to pharmacists and pharmacy technicians needed to successfully submit prescription information to the Alabama PDMP and enhances community pharmacists' understanding and utilization of the Alabama PDMP.

This CE is for pharmacists and pharmacy technicians and is 1.25 hours of continuing education credit.

Alabama's Prescription Drug Monitoring Program: The Essentials

Townhalls

The townhalls consist of an interactive PDMP demonstration and skills-building exercise led by Auburn personnel with support from ADPH staff. Attending can earn you two hours of continuing education.

• April 9, 2025 -- Auburn

If you have any questions or issues, please contact the Harrison College of Pharmacy, Office of Alumni and Professional Affairs at [email protected] or Auburn University's Center for Opioid Research, Education, and Outreach at [email protected]. Thank you for your interest in our programs.

The Alabama Health Professionals' Opioid and Pain Management Education (ALAHOPE)

The platform is live at alahope.org.

ALAHOPE is a product of the Prescribers and Dispensers Committee of the Alabama Opioid Overdose and Addiction Council. This work has been a collaboration of the Jefferson County Department of Health, the Department of Health Services Administration at the University of Alabama at Birmingham School of Health Professions, the Alabama Board of Medical Examiners, and multiple subject matter experts from across the state of Alabama. The target populations for this curriculum are health professions students at the undergraduate or graduate level and practicing healthcare professionals.

Physicians, dentists, pharmacists, nurses, and social workers can earn free continuing education credit. This content meets the new educational requirements of DEA-registered practitioners. For more information, see the MATE Training Letter.

This project was supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) Overdose Data to Action cooperative agreement. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS or the U.S. Government.